ScholarLens Back to search
2005•Xinjiang Yike Daxue xuebaoRequires access

The clinical value of transrectal ultrasound guided systematic 13 core prostate biopsy in prostate cancer diagnosis and stage

Xing Bi

Open publisher page 0 citations

Abstract

Objective: To evaluate the clinical value of transrectal ultrasound guided systematic 13 core prostate biopsy in prostate cancer diagnosis and stage. Methods: To selective corresponding standards patients, guided by transrectal ultrasound, the systemic 13 core prostate biopsy was done. Then numbered the .13 samples and pathologic tests were made. The clinical data, pathologic result and radiological stage patho logical stage were compared. Results: Thirty-five cases were demonstrated prostate cancer by pathology in the 142 patients who underwent prostate biopsy, 1 of stage B,16 of stage C, and 18 of stage D. Noted that, there was relevance between frequent of positive biopsy, PSA value, sample Gleason grade with prostate cancer stage. Conclusion: The 13 core prostate biopsy guided by transrectal ultrasound is very valuable, especially in prostate diagnosis and stage.

About this research paper

What this paper is about

Objective: To evaluate the clinical value of transrectal ultrasound guided systematic 13 core prostate biopsy in prostate cancer diagnosis and stage. Methods: To selective corresponding standards patients, guided by transrectal ultrasound, the systemic 13 core prostate biopsy was done. Then numbered the .13 samples and pathologic tests were made. The clinical data, pathologic result and radiological stage patho logical stage were compared. Results: Thirty-five cases were demonstrated prostate cancer by pathology in the 142 patients who underwent prostate biopsy, 1 of stage B,16 of stage C, and 18 of stage D. Noted that, there was relevance between frequent of positive biopsy, PSA value, sample Gleason grade with prostate cancer stage. Conclusion: The 13 core prostate biopsy guided by transrectal ultrasound is very valuable, especially in prostate diagnosis and stage.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To evaluate the clinical value of transrectal ultrasound guided systematic 13 core prostate biopsy in prostate cancer diagnosis and stage. Methods: To selective corresponding standards patients, guided by transrectal ultrasound, the systemic 13 core prostate biopsy was done. Then numbered the .13 samples and pathologic tests were made. The clinical data, pathologic result and radiological stage patho logical stage were compared. Results: Thirty-five cases were demonstrated prostate cancer by pathology in the 142 patients who underwent prostate biopsy, 1 of stage B,16 of stage C, and 18 of stage D. Noted that, there was relevance between frequent of positive biopsy, PSA value, sample Gleason grade with prostate cancer stage. Conclusion: The 13 core prostate biopsy guided by transrectal ultrasound is very valuable, especially in prostate diagnosis and stage.

Key concepts: Medicine, Prostate cancer, Stage (stratigraphy), Prostate, Biopsy, Prostate biopsy, Radiology, Ultrasound

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The clinical value of transrectal ultrasound guided systematic 13 core prostate biopsy in prostate cancer diagnosis and stage — Research Paper | ScholarLens